PubRank

R B Luftig

Author PubWeight™ 102.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A 1986 7.02
2 Properties of a P70 proteolytic factor of murine leukemia viruses. Cell 1977 2.41
3 Retroviral proteinases. Curr Top Microbiol Immunol 1990 2.41
4 Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core. Proc Natl Acad Sci U S A 1977 2.22
5 Interaction of bacteriophage T4 tail fiber components with a lipopolysaccharide fraction from Escherichia coli. J Mol Biol 1970 2.09
6 Bacteriophage T4 head morphogenesis. On the nature of gene 49-defective heads and their role as intermediates. J Mol Biol 1971 2.06
7 An electron microscope study of Rauscher leukemia virus. Virology 1971 1.92
8 Purification and reconstitution of HeLa cell microtubules. Biochemistry 1980 1.68
9 An ultrastructural study of virions and cores of reovirus type 3. Virology 1972 1.68
10 Adenovirus binds to rat brain microtubules in vitro. J Virol 1975 1.49
11 p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity. Virology 1982 1.48
12 Low response to hepatitis B virus vaccine in Costa Rican health-care workers. Hepatology 1998 1.39
13 Partial characterization of a P70 proteolytic factor that is present in purified virions of Rauscher leukemia virus (RLV). Biochem Biophys Res Commun 1977 1.37
14 In vitro polymerization of microtubules from HeLa cells. J Cell Biol 1978 1.34
15 Increased visualization of microtubules by an improved fixation procedure. J Histochem Cytochem 1977 1.31
16 Microtubule-associated proteins of HeLa cells: heat stability of the 200,000 mol wt HeLa MAPs and detection of the presence of MAP-2 in HeLa cell extracts and cycled microtubules. J Cell Biol 1982 1.30
17 Quantitation of the interaction between adenovirus types 2 and 5 and microtubules inside infected cells. Virology 1980 1.24
18 Bacteriophage T4 head morphogenesis. IV. Comparison of gene 16-, 17-, and 49-defective head structures. J Virol 1972 1.22
19 Association of HSP70 with the adenovirus type 5 fiber protein in infected HEp-2 cells. Virology 1991 1.21
20 Binding of adenovirus to microtubules. II. Depletion of high-molecular-weight microtubule-associated protein content reduces specificity of in vitro binding. J Virol 1977 1.18
21 Does the cytoskeleton play a significant role in animal virus replication? J Theor Biol 1982 1.17
22 Reovirus serotypes 1 and 3 differ in their in vitro association with microtubules. J Virol 1979 1.15
23 Bacteriophage T4 head morphogenesis. II. Studies on the maturation of gene 49-defective head intermediates. J Virol 1972 1.14
24 PCR amplification of HIV-1 proteinase sequences directly from lab isolates allows determination of five conserved domains. Virology 1992 1.13
25 Preparations enriched for "immature" murine leukemia virus particles that remain in tissue culture fluids are deficient in Pr65gag proteolyic activity. Virology 1980 1.12
26 Bacteriophage T4 head morphogenesis. Isolation, partial characterization, and fate of gene 21-defective tau-particles. Proc Natl Acad Sci U S A 1973 1.12
27 Further studies on the dimensions of viral and protein structures using the catalase crystal internal marker technique. J Ultrastruct Res 1968 1.10
28 Assembly of bacteriophage T4 tail fibers. II. Isolation and characterization of tail fiber precursors. J Mol Biol 1970 1.09
29 Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development. J Med Virol 1996 1.09
30 Physicochemical characterization and specificity of the murine leukaemia virus Pr65gag proteolytic factor. J Gen Virol 1980 1.08
31 Sequence of human enteric adenovirus type 41 Tak fiber protein gene. Nucleic Acids Res 1989 1.08
32 Comparative immunofluorescence of murine leukemia virus-derived membrane-associated antigens. Virology 1983 1.07
33 Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product. J Virol 1978 1.06
34 An ultrastructural study of C-type virion assembly in mouse cells. Cancer Res 1974 1.05
35 Isolation of bacteriophage infectious for Vibrio vulnificus. Curr Microbiol 1995 1.04
36 Human enteric adenovirus type 41 (Tak) contains a second fiber protein gene. Nucleic Acids Res 1990 1.03
37 A comparison of avian and murine retrovirus polyprotein cleavage activities. Virology 1981 0.98
38 Effect of interferon on dimethyl sulfoxide-stimulated Friend erythroleukemic cells: ultrastructural and biochemical study. J Virol 1977 0.96
39 Bacteriophage T4 head morphogenesis. 3. Some novel properties of gene 13-defective heads. J Virol 1972 0.96
40 Human adenovirus type 41 contains two fibers. Virus Res 1994 0.95
41 Characterization of Rauscher Leukemia virus (RLV) P40-42, an intermediate cleavage product of the group specific antigen (gag) precursor polypeptide, P65-70. Biochem Biophys Res Commun 1977 0.94
42 Hydrodynamic diameters of murine mammary, Rous sarcoma, and feline leukemia RNA tumor viruses: studies by laser beat frequency light-scattering spectroscopy and electron microscopy. J Virol 1976 0.94
43 Morphological conversion of 'immature' Rauscher leukaemia virus cores to a 'mature' form after addition of the P65-70 (gag gene product) proteolytic factor. J Gen Virol 1978 0.92
44 Microtubule-depolymerizing agents inhibit Moloney murine leukaemia virus production. J Gen Virol 1982 0.92
45 In vitro phosphorylation of murine leukemia virus proteins: specific phosphorylation of Pr65gag, the precursor of the internal core antigens. Virology 1982 0.91
46 Nucleotide sequence of human enteric adenovirus type 41 hexon-associated protein VIII precursor (pVIII) including the early region E3 promoter. Nucleic Acids Res 1989 0.89
47 Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J Virol 1995 0.88
48 The morphology of the immature HIV-1 virion. Virology 1997 0.86
49 Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J Clin Microbiol 1997 0.86
50 Differential growth of human enteric adenovirus 41 (TAK) in continuous cell lines. Virology 1990 0.86
51 Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests. J Med Virol 1999 0.85
52 Bacteriophage T4 head morphogenesis. V. The role of DNA synthesis in maturation of an intermediate in head assembly. Virology 1973 0.85
53 Murine retrovirus Pr65gag forms a 130K dimer in the absence of disulfide reducing agents. Virology 1984 0.84
54 Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int Immunol 1997 0.84
55 A determination of the outer dimensions of oncornaviruses by several electron microscopic procedures. Cancer Res 1974 0.83
56 AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. Virus Res 1997 0.83
57 Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin. Virology 1986 0.83
58 The effect of cerulenin on Moloney murine leukemia virus morphogenesis. Virus Res 1986 0.83
59 Effect of vinblastine on distribution of murine leukemia virus-derived membrane-associated antigens. Proc Natl Acad Sci U S A 1981 0.83
60 Stabilization of actin filaments at early times after adenovirus infection and in heat-shocked cells. Virus Res 1991 0.83
61 Murine leukaemia virus p30 heterogeneity as revealed by two-dimensional gel electrophoresis is not an artefact of the technique. J Gen Virol 1984 0.82
62 Bacteriophage T4 head morphogenesis. VII. Terminal stages of head maturation. J Virol 1976 0.82
63 Physiocochemical studies on L-cell virions. J Virol 1973 0.81
64 Preservation of membrane ultrastructure with aldehyde or imidate fixatives. J Ultrastruct Res 1975 0.81
65 Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes. AIDS Res Hum Retroviruses 1997 0.81
66 Detection of phosphorylated forms of Moloney murine leukemia virus major capsid protein p30 by immunoprecipitation and two-dimensional gel electrophoresis. J Virol 1988 0.81
67 Preservation of erythrocyte ghost ultrastructure achieved by various fixatives. Proc Natl Acad Sci U S A 1973 0.80
68 Aminopeptidase activity associated with purified murine leukaemia viruses. J Gen Virol 1980 0.80
69 Separation of a murine leukaemia virus protein kinase activity from its Pr65gag polyprotein substrate after DNA--cellulose chromatography. J Gen Virol 1983 0.80
70 Quantitation of endogenous C-type virion production in several murine cell lines. J Virol 1974 0.80
71 Differences in the pI heterogeneity of virion and intracellular Moloney murine leukaemia virus p30s. J Gen Virol 1987 0.79
72 Human enteric adenovirus type 41 binding to HEp-2 cells is specific. Virology 1991 0.79
73 Bacteriophage T4D head morphogenesis. VIII. DNA-protein associations in intermediate head structures that accumulate in gene 49--mutant-infected cells. J Virol 1977 0.79
74 Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41. J Virol 1996 0.78
75 Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis. Microbiol Mol Biol Rev 2000 0.78
76 Outer membrane of avian myeloblastosis virus. J Virol 1973 0.78
77 Serial passage of human immunodeficiency virus type 1 generates misalignment deletions in non-essential accessory genes. Virus Res 1996 0.78
78 Morphological, chemical, and antigenic organization of mammalian C-type viruses. Bibl Haematol 1975 0.77
79 The adenovirus type 5 capsid protein IIIa is phosphorylated during an early stage of infection of HeLa cells. Virology 1983 0.77
80 Nucleotide sequence of the region coding for 100K and 33K proteins of human enteric adenovirus type 41 (Tak). Nucleic Acids Res 1990 0.77
81 Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus. Virology 1993 0.77
82 Evidence for the ubiquitous presence of a protein kinase in human adenoviruses capable of preferentially phosphorylating capsid protein IIIa. Intervirology 1985 0.77
83 A rapid screening method for biological activity of human immunodeficiency virus proteinase inhibitors by using a recombinant DNA-derived bacterial system. Anal Biochem 1993 0.77
84 A dominant epitope of HIV-1 protease recognized by hamster monoclonal antibodies. J Acquir Immune Defic Syndr 1993 0.77
85 Enteric adenovirus 41 (Tak) requires low serum for growth in human primary cells. Virology 1990 0.77
86 The effect of cerulenin on the synthesis of the precursor gag polyprotein in defective murine leukemia and sarcoma virus producing cell lines. Virology 1986 0.77
87 Inhibition of bacterially expressed HIV protease activity determined by an in vitro cleavage assay with MuLV Pr65gag. AIDS Res Hum Retroviruses 1989 0.77
88 The importance of adequate fixation in preservation of membrane ultrastructure. Int Rev Cytol Suppl 1981 0.77
89 Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles. Virus Res 2000 0.75
90 Inhibition of murine leukemia virus Pr65gag cleavage in vitro and in vivo by hypertonic medium. J Virol 1981 0.75
91 Cleavage of Rauscher leukaemia virus (R-MuLV) Pr65gag by the Moloney leukaemia virus (M-MuLV) proteolytic activity produces the R-MuLV-specific but not the M-MuLV-specific 40 000 dalton intermediate polypeptide. J Gen Virol 1981 0.75
92 A specific T-cell subset with CD4+/CD38- markers derived from HIV-1 carriers induces apoptosis in healthy donor-derived T-lymphocytes. Virus Res 1998 0.75
93 Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules. Virus Res 2001 0.75
94 Evidence for the existence of a thermolabile element in adenovirus type 5 that plays a role during an early stage of infection. Virus Res 1985 0.75
95 An unexpected effect of divalent cations on the adenovirus endogenous protein kinase: alteration in the specificity of phosphorylation. Virus Res 1985 0.75
96 Reduction-modifiable properties of Moloney murine leukemia virus gp70 as an indicator of envelope glycoprotein heterogeneity. Intervirology 1989 0.75
97 The unit membrane image: a re-evaluation. Life Sci 1977 0.75
98 In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30. J Gen Virol 1985 0.75
99 Characterization of a conformationally sensitive epitope on Moloney murine leukemia virus gp70. Intervirology 1987 0.75
100 Induction of apoptosis by protease-defective particle preparations of human immunodeficiency virus type 1 is specific to a subset of U937-derived subclones. Int Immunol 1996 0.75
101 The cytoskeleton of murine leukemia virus (MuLV)-infected mouse fibroblasts as observed under varying conditions of formaldehyde fixation. Cell Motil 1983 0.75
102 Antigenic differences among multiply charged Moloney murine leukemia virus p30 polypeptides found inside infected cells. Virus Res 1986 0.75
103 A cell-determined deficiency in the processing of gag proteins of murine leukemia virus 334C. Virology 1981 0.75
104 Interaction of retroviruses with chemical carcinogens. Covalent binding of (+/-)7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha, epoxy-7,8,9.10-tetrahydrobenzo[a]pyrene. Arch Biochem Biophys 1980 0.75
105 Interactions of retroviruses with chemical carcinogen. I. Noncovalent binding of unactivated polycyclic aromatic hydrocarbons. Virology 1979 0.75
106 Strategies in phage and animal virus morphogenesis. Prog Clin Biol Res 1981 0.75